Bronchial Asthma Research Paper

Bronchial asthma is a chronic inflammatory airways disorder which leads to bronchoconstriction of the trachea and shorten the breath. It is a global serious health problem, where 5% to 10% of different age peoples suffer this disorder (Ukena, Fishman, & Niebling, 2008). Bronchial asthma has many manifestations as the recurrent acute shortness of breath episodes, which typically occur at night and early morning hours. In addition, it could cause other symptoms including wheezing, coughing, and feeling chest tightness. These symptoms mostly arise after physical exercises. The symptoms differ depending on the severity of the individuals, thus, bronchial asthma is defined as the chronic inflammatory disease which is characterized by bronchial hyper reactivity and variable degree of the airway obstructions (Buhl et al., 2006). The hyper reactivity of the bronchus can be stimulated by such allergens, cold air, environmental chemicals, viruses, and aspirin-type drugs.
Most of bronchial asthma in childhood is due to allergic factors; meanwhile, 30% to 50% of the asthma in adult is due to other factors as viral infection of lower respiratory tract. Asthma can be either allergic, which is also called extrinsic asthma, or intrinsic asthma which is not known as
It is mostly used in treating those patients with exercise-induced bronchospasm. The most common adverse effects of using albuterol are extremities shaking, dizziness, nausea, muscle pain, diarrhea, etc. The effect of using Albuterol depends on the dosage administrated. Cardiovascular symptoms as irregular heart rhythms, tachycardia, and high blood pressure can be occur as sympathomimetic effects of albuterol. This could affect the rehabilitation program. It was found that Albuterol inhalation could enhance the performance during the submaximal exercise (Collomp et al.,